DE60310958D1 - Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen - Google Patents

Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen

Info

Publication number
DE60310958D1
DE60310958D1 DE60310958T DE60310958T DE60310958D1 DE 60310958 D1 DE60310958 D1 DE 60310958D1 DE 60310958 T DE60310958 T DE 60310958T DE 60310958 T DE60310958 T DE 60310958T DE 60310958 D1 DE60310958 D1 DE 60310958D1
Authority
DE
Germany
Prior art keywords
vectectization
characterization
molecules
introduction
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310958T
Other languages
English (en)
Other versions
DE60310958T2 (de
Inventor
Pascal Dumy
Marie-Christine Favrot
Didier Boturyn
Jean-Luc Coll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Joseph Fourier Grenoble 1
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Joseph Fourier Grenoble 1
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0211614A external-priority patent/FR2844798B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Joseph Fourier Grenoble 1, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60310958D1 publication Critical patent/DE60310958D1/de
Publication of DE60310958T2 publication Critical patent/DE60310958T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60310958T 2002-09-19 2003-09-19 Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen Expired - Lifetime DE60310958T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41184502P 2002-09-19 2002-09-19
FR0211614A FR2844798B1 (fr) 2002-09-19 2002-09-19 Synthese et caracterisation de nouveaux systemes de guidage et de vectorisation de molecules d'interet therapeutique vers des cellules cibles
US411845P 2002-09-19
FR0211614 2002-09-19
PCT/FR2003/002773 WO2004026894A2 (fr) 2002-09-19 2003-09-19 Synthese et caracterisation de nouveaux systemes de guidage et de vectorisation de compose doues d’activite therapeutique

Publications (2)

Publication Number Publication Date
DE60310958D1 true DE60310958D1 (de) 2007-02-15
DE60310958T2 DE60310958T2 (de) 2007-10-11

Family

ID=32031840

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310958T Expired - Lifetime DE60310958T2 (de) 2002-09-19 2003-09-19 Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen

Country Status (8)

Country Link
US (1) US7531622B2 (de)
EP (1) EP1539804B1 (de)
JP (1) JP4657721B2 (de)
AT (1) ATE350393T1 (de)
AU (1) AU2003299038A1 (de)
CA (1) CA2499496C (de)
DE (1) DE60310958T2 (de)
WO (1) WO2004026894A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888753B1 (fr) * 2005-07-21 2008-04-04 Commissariat Energie Atomique Vecteur cible avec fonction d'imagerie activable
FR2897616B1 (fr) * 2006-02-20 2008-05-30 Univ Grenoble 1 Presentation de motifs de reconnaissance par une matrice multivalente greffee sur un support solide
WO2010076334A2 (en) 2008-12-31 2010-07-08 Centre Leon Berard Intraoperative diagnosis of primary tumors and secondary tumors or metastases
FR2959993B1 (fr) * 2010-05-17 2014-10-17 Commissariat Energie Atomique Nouveaux composes cyclodecapeptides et leurs applications
FR2989280B1 (fr) 2012-04-13 2017-02-24 Univ Claude Bernard Lyon Nanoparticules ultrafines comme agent de contraste multimodal
US10988531B2 (en) 2014-09-03 2021-04-27 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
FR3036621B1 (fr) 2015-05-25 2017-05-19 Fluoptics Traceur fluorescent ciblant multivalent dans le proche infrarouge pour imagerie optique.
FR3072281B1 (fr) 2017-10-13 2020-12-04 Nh Theraguix Nanovecteurs et utilisations, en particulier pour le traitement de tumeurs
CN111233975A (zh) * 2018-11-28 2020-06-05 复旦大学 可靶向整合素的多肽mn及其在制备肿瘤靶向药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL138093A0 (en) * 1998-03-31 2001-10-31 Du Pont Pharm Co Pharmaceuticals for the imaging of angiogenic disorders
US20030125243A1 (en) * 2000-07-20 2003-07-03 Jun Liu Synthesis of cyclic peptides

Also Published As

Publication number Publication date
DE60310958T2 (de) 2007-10-11
JP4657721B2 (ja) 2011-03-23
ATE350393T1 (de) 2007-01-15
AU2003299038A8 (en) 2004-04-08
EP1539804A2 (de) 2005-06-15
CA2499496C (fr) 2012-04-24
JP2006514919A (ja) 2006-05-18
WO2004026894A2 (fr) 2004-04-01
EP1539804B1 (de) 2007-01-03
US20060173160A1 (en) 2006-08-03
AU2003299038A1 (en) 2004-04-08
US7531622B2 (en) 2009-05-12
WO2004026894A3 (fr) 2004-06-24
CA2499496A1 (fr) 2004-04-01

Similar Documents

Publication Publication Date Title
DK1231279T3 (da) Fremgangsmåde til fremstilling af tripeptider
DE602004001727D1 (de) Verfahren zur herstellung cyclischer peptide
EP2402369A3 (de) Peptidfragmente zur Induzierung der Synthese extrazellulärer Matrixproteine
EP2338333A3 (de) Glycopegylierungsverfahren und durch die Verfahren hergestellte Proteine/Peptide
DE69732640D1 (de) Festphasen-peptidsynthese
EP1908773A3 (de) Verfahren zur Herstellung von Dipeptiden
DE60310958D1 (de) Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen
NO20072661L (no) Rensing av glykopeptider
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
He et al. Total synthesis of proposed structure of coibamide A, a highly N-and O-methylated cytotoxic marine cyclodepsipeptide
WO2005065339A3 (en) Cell cycle genes and related methods of using
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
WO2007093848A3 (en) Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori
IL149158A0 (en) Tailored peptide synthetases, a method for their production and the use thereof
WO2004094590A3 (en) Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
EP1553184A4 (de) Verfahren zur herstellung eines tripeptids oder höheren peptids
Kim et al. Activity profiles of linear, cyclic monomer and cyclic dimer of enkephalin
Chen et al. An efficient stereoselective synthesis of [3S (1S, 9S)]-3-[[[9-(benzoylamino) octahydro-6, 10-dioxo-6H-pyridazino-(1, 2-a)(1, 2)-diazepin-1-yl]-carbonyl] amino]-4-oxobutanoic acid, an interleukin converting enzyme (ICE) inhibitor
Butler et al. Synthesis of backbone modified cyclic peptides bearing dipicolylamino sidearms
Jacinto et al. Synthesis and bioactivity of nobilamide B
DK2094841T3 (da) Fremgangsmåde til fremstilling af pravastatin
AU2003273953A8 (en) Method for synthesizing peptides comprising at least one glycine molecule
Di Gioia et al. A convenient method for the stereoselective conversion of aryl peptidyl ketones into the corresponding aryl aminomethin derivatives, a novel class of modified peptides
Venneri et al. Simple and Mild One-Pot Synthesis of Dipeptidyl Ureas via Carbamoyl Azides of α-N-Protected Amino Acids
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition